Key statistics
On Friday, Entrada Therapeutics Inc (TRDA:NMQ) closed at 14.68, -19.21% below its 52-week high of 18.17, set on Jul 16, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 14.84 |
---|---|
High | 15.09 |
Low | 14.55 |
Bid | 14.65 |
Offer | 15.89 |
Previous close | 15.00 |
Average volume | 154.33k |
---|---|
Shares outstanding | 37.20m |
Free float | 31.62m |
P/E (TTM) | 4.96 |
Market cap | 546.09m USD |
EPS (TTM) | 2.96 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
- Entrada Therapeutics Announces Recipients of Second Annual Diversity, Representation, Equity and Advocacy MatterS (DREAMS) Grant Program
- Entrada Therapeutics Reports Second Quarter 2024 Financial Results
- Entrada Therapeutics Announces $100 Million Registered Direct Offering
- Entrada Therapeutics Reports Positive Preliminary Data in Healthy Volunteers from Phase 1 ENTR-601-44-101 Trial for Duchenne Muscular Dystrophy
- Entrada Therapeutics to Present at Goldman Sachs 45th Annual Global Healthcare Conference
- Entrada Therapeutics to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
- Entrada Therapeutics Reports First Quarter 2024 Financial Results
- Entrada Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
- Entrada Therapeutics to Present at Upcoming Investor Conferences
- Entrada Therapeutics Promotes Nathan J. Dowden to President
More ▼